Christa Myers to lead roundtable on EU GMP Annex 1 at PharmaXchange 2025

The global regulatory landscape is shifting. Are you prepared? A wave of coordinated action on colorants, like the Red Dye No. 3 ban, is transforming the pharmaceutical industry. This isn't just a regional issue; it's a global transformation demanding proactive solutions. Swipe through to see how regulations are evolving across the globe and how Kerry can help you stay ahead. Learn More: https://lnkd.in/dmPb7Kze #Kerrypharma #KerryTabletCoatings #RegulatoryExpertise

The pharmaceutical industry is undergoing a profound transformation. New regulations on colorants — such as the recent ban on Red No. 3 — signal the beginning of a global shift, not just a regional one. Swipe through to see how regulations are evolving across different countries and how Kerry Solutions for Pharma can help you turn these challenges into strategic opportunities.

What’s ahead for medical packaging? In our latest video, expert Mahesh Koté, MS, M.B.A. breaks down how updates to USP 661.1 and 661.2 are shaping the future of material qualification and compliance in the medical device and pharmaceutical industries. Watch now to learn what these changes mean for manufacturers and how we can help ensure packaging meets the latest standards. #sgsnorthamerica #medicalpackaging #pharmaceuticaltesting #whenyouneedtobesure

Our second article in the Pharma Packaging Insight Series is now live! In this blog, we break down the types of pharmaceutical labels and the factors that influence label selection.   You can read the full article on our Resources page here: https://lnkd.in/gcyq_zZ2 #pharma #pharmablog #pharmanews #pharmapackaging #labels

Evidenced Compliancy. Relevant in Pharma. www.ActARion.com (Authorized distributor of www.DeepSight.ca) helps Contract Manufacturing Operators in the pharmaceutical industry enhance process reliability and compliance through AR-guided, step-by-step digital work instructions. This reduces human error, ensures consistent execution across shifts, and automatically documents every task for audit readiness. As a result, CMOs can increase efficiency, maintain GMP standards more easily and with evidence. This strengthens trust with their clients. To explore this venture together we will come to the CPHI Expo in Frankfurt on Wednesday 29th October. https://lnkd.in/dCqeQbZK

💊 The restructuring of the FDA, its workforce turnover, and changing expectations regarding pharmaceutical innovation and compliance have created a climate of regulatory uncertainty. Our latest blog provides some useful tips for pharmaceutical leaders looking to adapt to a regulatory landscape in a constant state of flux. Read it now at https://lnkd.in/duCQKxnn #pharmaceuticalindustry #regulatorycompliance

In the evolving landscape of pharmaceutical compliance, the FDA’s stance on audit trails has become increasingly pivotal. This article delves into the FDA’s latest guidance on implementing and managing audit trails, highlighting best practices, regulatory expectations, and the critical role these trails play in ensuring data integrity and compliance. By the way, I am looking forward to presenting tomorrow’s Warning Letter Wednesday’s seminar around 11:00 AM central on the features and capabilities of the GKS KeyPedia AI Assistant (@globalkeysolutions). If you have not registered yet, do so at your earliest convenience. 

JBT Automated Systems’ AGVs enable end-to-end traceability and consistent material movement — essential for continuous pharmaceutical manufacturing and regulatory readiness. - Automated material flow - Real-time tracking - Reliable, compliant performance Discover automation built for modern pharma production: https://brnw.ch/21wXr2U #JBTAutomatedSystems #PharmaAutomation #ContinuousManufacturing #Traceability #AutomationSolutions

The FDA’s finalized guidance on Scientific Information on Unapproved Uses (SIUU) is reshaping how pharmaceutical companies approach scientific exchange. Our experts, Anne Marie Robertson, Tim Lewis and Susan Giacalone MSN, MSL-BC, BCMAS, unpack key updates from the guidance and share how organizations can align strategy with compliance. The goal is to empower field teams to communicate confidently, credibly, and within regulatory boundaries. From expanded flexibility for field personnel to actionable insights, discover how to make the most of this new framework while maintaining scientific integrity. Read the full article: https://ow.ly/jcc650XhMo2 #MedicalAffairs #EmergingPharma #Compliance

“The Future of Pharma Manufacturing” — A visual roadmap highlighting key industry challenges, technological advancements, regulatory alignment, and Geopharm’s role in driving innovation and efficiency in pharmaceutical production. #PharmaManufacturing #PharmaceuticalInnovation #AdvancedManufacturing #PharmaTechnology #RegulatoryCompliance #Automation #ContinuousManufacturing #FutureOfPharma #Geopharm #PharmaEngineering